CharlesW. M.RobertsMDPhD
Pediatric Hematology & Oncology • Memphis, TNCancer Center Director and EVP, St. Jude Children's Research Hospital
Dr. Roberts is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105- Is this information wrong?
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1997 - 2000- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1995 - 1997
Washington University in St. Louis School of MedicineClass of 1995
Certifications & Licensure
TN State Medical License 2016 - 2025
MA State Medical License 1997 - 2016- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Publications & Presentations
PubMed
- 1019 citationsTargeting EZH2 in cancerKimberly H. Kim, Charles W. M. Roberts
Nature Medicine. 2016-02-01 - 114 citationsBRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumorsXiaofeng Wang, Su Wang, Emma C. Troisi, Thomas P. Howard, Jeffrey R. Haswell
Nature Communications. 2019-04-23 - 473 citationsThe SWI/SNF complex--chromatin and cancer.Charles W. M. Roberts, Stuart H. Orkin
Nature Reviews. Cancer. 2004-02-01
Press Mentions
- Mithramycin Induces Promoter Reprogramming and Differentiation of Rhabdoid TumorDecember 17th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
